BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34705247)

  • 1. Screening and Identification of Potential iNOS Inhibitors to Curtail Cervical Cancer Progression: an In Silico Drug Repurposing Approach.
    Poleboyina PK; Rampogu S; Doneti R; Pasha A; Poleboyina SM; Bhanothu S; Pasumarthi D; S D A; Kumbhakar D; Lee KW; Pawar SC
    Appl Biochem Biotechnol; 2022 Jan; 194(1):570-586. PubMed ID: 34705247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and
    Pasha A; Kumbhakar DV; Doneti R; Kumar K; Dharmapuri G; Poleboyina PK; S K H; Basavaraju P; Pasumarthi D; S D A; Soujanya P; Arnold Emeson I; Bodiga V; Pawar SC
    Oxid Med Cell Longev; 2021; 2021():6692628. PubMed ID: 33815659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
    Kami Reddy KR; Dasari C; Vandavasi S; Natani S; Supriya B; Jadav SS; Sai Ram N; Kumar JM; Ummanni R
    ACS Comb Sci; 2019 Apr; 21(4):241-256. PubMed ID: 30673277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual Screening, Molecular Docking, and Dynamic Simulations Revealed TGF-β1 Potential Inhibitors to Curtail Cervical Cancer Progression.
    Poleboyina PK; Naik U; Pasha A; Ravinder D; Bhanothu S; Poleboyina SM; Amineni U; Pawar SC
    Appl Biochem Biotechnol; 2024 Mar; 196(3):1316-1349. PubMed ID: 37392324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
    Maccallini C; Di Matteo M; Gallorini M; Montagnani M; Graziani V; Ammazzalorso A; Amoia P; De Filippis B; Di Silvestre S; Fantacuzzi M; Giampietro L; Potenza MA; Re N; Pandolfi A; Cataldi A; Amoroso R
    Eur J Med Chem; 2018 May; 152():53-64. PubMed ID: 29689474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the structural determinants for selective inhibition of nitric oxide synthase isoforms.
    Oliveira BL; Moreira IS; Fernandes PA; Ramos MJ; Santos I; Correia JD
    J Mol Model; 2013 Apr; 19(4):1537-51. PubMed ID: 23263357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of pharmacophore modeling, molecular docking and virtual screening for iNOS inhibitors from Chinese herbs.
    Wang X; Ren Z; He Y; Xiang Y; Zhang Y; Qiao Y
    Biomed Mater Eng; 2014; 24(1):1315-22. PubMed ID: 24212027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.
    Arias F; Franco-Montalban F; Romero M; Carrión MD; Camacho ME
    Bioorg Med Chem; 2021 Aug; 44():116294. PubMed ID: 34218000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for Potential Inducible Nitric Oxide Synthase Inhibitors with Favorable ADMET Profiles for the Therapy of Helicobacter pylori Infections.
    Rodrigues RP; Ardisson JS; Ribeiro Gonçalves RC; Oliveira TB; Barreto da Silva V; Kawano DF; Kitagawa RR
    Curr Top Med Chem; 2019; 19(30):2795-2804. PubMed ID: 31721712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
    Bonnefous C; Payne JE; Roppe J; Zhuang H; Chen X; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Severance D; Walsh JP; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
    J Med Chem; 2009 May; 52(9):3047-62. PubMed ID: 19374401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics).
    Özenver N; Efferth T
    Biochem Pharmacol; 2020 Jun; 176():113792. PubMed ID: 31926145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, docking and evaluation of in vitro anti-inflammatory activity of novel morpholine capped β-lactam derivatives.
    Heiran R; Sepehri S; Jarrahpour A; Digiorgio C; Douafer H; Brunel JM; Gholami A; Riazimontazer E; Turos E
    Bioorg Chem; 2020 Sep; 102():104091. PubMed ID: 32717692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inducible nitric-oxide synthase dimerization inhibition by novel pyrimidine imidazoles.
    Nagpal L; Haque MM; Saha A; Mukherjee N; Ghosh A; Ranu BC; Stuehr DJ; Panda K
    J Biol Chem; 2013 Jul; 288(27):19685-97. PubMed ID: 23696643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a natural product-like iNOS inhibitor by molecular docking with potential neuroprotective effects in vivo.
    Zhong HJ; Liu LJ; Chong CM; Lu L; Wang M; Chan DS; Chan PW; Lee SM; Ma DL; Leung CH
    PLoS One; 2014; 9(4):e92905. PubMed ID: 24690920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration.
    Xu J; Luo Y; Yuan C; Han L; Wu Q; Xu L; Gao Y; Sun Y; Ma S; Tang G; Li S; Sun W; Gong Y; Xie C
    Int J Biol Sci; 2020; 16(9):1563-1574. PubMed ID: 32226302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
    Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
    Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor.
    Dong J; Cheng M; Sun H
    Mol Med Rep; 2014 Feb; 9(2):583-9. PubMed ID: 24297386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
    Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
    J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
    Gericke A; Goloborodko E; Sniatecki JJ; Steege A; Wojnowski L; Pfeiffer N
    Exp Eye Res; 2013 Apr; 109():60-6. PubMed ID: 23434456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.